Paul McCullagh
Overview
Explore the profile of Paul McCullagh including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
32
Citations
408
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Munkley J, McClurg U, Livermore K, Ehrmann I, Knight B, McCullagh P, et al.
Sci Rep
. 2017 Jul;
7(1):5249.
PMID: 28701765
Cell migration drives cell invasion and metastatic progression in prostate cancer and is a major cause of mortality and morbidity. However the mechanisms driving cell migration in prostate cancer patients...
12.
Davies R, Parker J, McCullagh P, Zheng H, Nugent C, Black N, et al.
JMIR Rehabil Assist Technol
. 2017 Jun;
3(2):e11.
PMID: 28582260
Background: In the United Kingdom, stroke is the single largest cause of adult disability and results in a cost to the economy of £8.9 billion per annum. Service needs are...
13.
Munkley J, Vodak D, Livermore K, James K, Wilson B, Knight B, et al.
EBioMedicine
. 2016 Jul;
8:103-116.
PMID: 27428423
Steroid androgen hormones play a key role in the progression and treatment of prostate cancer, with androgen deprivation therapy being the first-line treatment used to control cancer growth. Here we...
14.
Munkley J, Livermore K, McClurg U, Kalna G, Knight B, McCullagh P, et al.
Oncoscience
. 2015 Oct;
2(9):755-64.
PMID: 26501081
Androgen receptor (AR) signalling and the PI3K pathway mediate survival signals in prostate cancer, and have been shown to regulate each other by reciprocal negative feedback, such that inhibition of...
15.
Munkley J, Oltean S, Vodak D, Wilson B, Livermore K, Zhou Y, et al.
Oncotarget
. 2015 Oct;
6(33):34358-74.
PMID: 26452038
Patterns of glycosylation are important in cancer, but the molecular mechanisms that drive changes are often poorly understood. The androgen receptor drives prostate cancer (PCa) development and progression to lethal...
16.
Martin S, Augusto J, McCullagh P, Carswell W, Zheng H, Wang H, et al.
Int J Environ Res Public Health
. 2013 Dec;
10(12):6764-82.
PMID: 24304507
Strategies to support people living with dementia are broad in scope, proposing both pharmacological and non-pharmacological interventions as part of the care pathway. Assistive technologies form part of this offering...
17.
Duggan G, Keogh E, Mountain G, McCullagh P, Leake J, Eccleston C
Disabil Rehabil Assist Technol
. 2013 Oct;
10(1):53-60.
PMID: 24112276
Purpose: Technology could support the self-management of long-term health conditions such as chronic pain. This article describes an evaluation of SMART2, a personalised self-management system incorporating activity planning and review,...
18.
Verkerke G, van der Houwen E, Broekhuis A, Bursa J, Catapano G, McCullagh P, et al.
J Mech Behav Biomed Mater
. 2013 Apr;
21:195-201.
PMID: 23566771
Science and design are two completely separated areas of expertise with their own specialists. Science analyses the existing world to create new knowledge, design uses existing knowledge to create a...
19.
Flynn C, Oxley J, McCullagh P, McCluggage W
Int J Gynecol Pathol
. 2012 Dec;
32(1):141-5.
PMID: 23202781
Serous carcinomas most commonly arise within the uterine corpus or ovary/fallopian tube, but there are 2 prior case reports of primary vaginal serous carcinoma. We report 2 examples of high-grade...
20.
ONeill S, Nugent C, Donnelly M, McCullagh P, McLaughlin J
Technol Health Care
. 2012 Jun;
20(3):151-67.
PMID: 22735731
With current advances in sensing technology, communication networks and software applications, the use of connected health technology within the home environment has become both more affordable and widespread. Nevertheless, the...